367 related articles for article (PubMed ID: 25889426)
1. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.
Chen DY; Chen YM; Hsieh TY; Hsieh CW; Lin CC; Lan JL
Arthritis Res Ther; 2015 Mar; 17(1):52. PubMed ID: 25889426
[TBL] [Abstract][Full Text] [Related]
2. Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.
Cacciapaglia F; Anelli MG; Rinaldi A; Fornaro M; Lopalco G; Scioscia C; Lapadula G; Iannone F
Mediators Inflamm; 2018; 2018():2453265. PubMed ID: 30405318
[TBL] [Abstract][Full Text] [Related]
3. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.
El-Barbary AM; Kassem EM; El-Sergany MA; Essa SA; Eltomey MA
J Rheumatol; 2011 May; 38(5):828-34. PubMed ID: 21362765
[TBL] [Abstract][Full Text] [Related]
4. Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.
Schimmel EK; Yazici Y
Clin Exp Rheumatol; 2009; 27(3):446-51. PubMed ID: 19604437
[TBL] [Abstract][Full Text] [Related]
5. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
[TBL] [Abstract][Full Text] [Related]
7. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
Dahlqvist SR; Engstrand S; Berglin E; Johnson O
Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
Benucci M; Turchini S; Parrochi P; Boccaccini P; Manetti R; Cammelli E; Manfredi M
Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418
[TBL] [Abstract][Full Text] [Related]
10. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
[TBL] [Abstract][Full Text] [Related]
11. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
[TBL] [Abstract][Full Text] [Related]
12. Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.
Umekita K; Hidaka T; Miyauchi S; Ueno S; Kubo K; Takajo I; Hashiba Y; Kai Y; Nagatomo Y; Okayama A
Arthritis Care Res (Hoboken); 2014 May; 66(5):788-92. PubMed ID: 24127184
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis.
Braun-Moscovici Y; Markovits D; Zinder O; Schapira D; Rozin A; Ehrenburg M; Dain L; Hoffer E; Nahir AM; Balbir-Gurman A
J Rheumatol; 2006 Mar; 33(3):497-500. PubMed ID: 16511906
[TBL] [Abstract][Full Text] [Related]
16. The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study.
Papamichail GV; Markatseli TE; Georgiadis AN; Xydis VG; Milionis H; Drosos AA; Voulgari PV
Heart Vessels; 2022 Dec; 37(12):2128-2136. PubMed ID: 35739432
[TBL] [Abstract][Full Text] [Related]
17. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
Allanore Y; Kahan A; Sellam J; Ekindjian OG; Borderie D
Clin Chim Acta; 2006 Mar; 365(1-2):143-8. PubMed ID: 16176811
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy.
Curtis JR; John A; Baser O
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1282-91. PubMed ID: 22504829
[TBL] [Abstract][Full Text] [Related]
20. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
